Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal Impairment
Clinical trial NCT01239459 · COMPLETED
Trial details
- NCT number
- NCT01239459
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-02-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.